229 related articles for article (PubMed ID: 28502477)
1. Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.
Kyritsi K; Meng F; Zhou T; Wu N; Venter J; Francis H; Kennedy L; Onori P; Franchitto A; Bernuzzi F; Invernizzi P; McDaniel K; Mancinelli R; Alvaro D; Gaudio E; Alpini G; Glaser S
Am J Pathol; 2017 Jul; 187(7):1551-1565. PubMed ID: 28502477
[TBL] [Abstract][Full Text] [Related]
2. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
[TBL] [Abstract][Full Text] [Related]
3. Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.
McMillin M; DeMorrow S; Glaser S; Venter J; Kyritsi K; Zhou T; Grant S; Giang T; Greene JF; Wu N; Jefferson B; Meng F; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G410-G418. PubMed ID: 28751425
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanisms.
Ray D; Han Y; Franchitto A; DeMorrow S; Meng F; Venter J; McMillin M; Kennedy L; Francis H; Onori P; Mancinelli R; Gaudio E; Alpini G; Glaser SS
Am J Pathol; 2015 Apr; 185(4):1061-72. PubMed ID: 25794706
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2
Kyritsi K; Francis H; Zhou T; Ceci L; Wu N; Yang Z; Meng F; Chen L; Baiocchi L; Kundu D; Kennedy L; Liangpunsakul S; Wu C; Glaser S; Alpini G
Gene Expr; 2020 Nov; 20(2):89-103. PubMed ID: 32393417
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
Xiao Y; Wang J; Chen Y; Zhou K; Wen J; Wang Y; Zhou Y; Pan W; Cai W
Cell Signal; 2014 May; 26(5):925-32. PubMed ID: 24412919
[TBL] [Abstract][Full Text] [Related]
7. Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.
Chen L; Zhou T; Wu N; O'Brien A; Venter J; Ceci L; Kyritsi K; Onori P; Gaudio E; Sybenga A; Xie L; Wu C; Fabris L; Invernizzi P; Zawieja D; Liangpunsakul S; Meng F; Francis H; Alpini G; Huang Q; Glaser S
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1525-1539. PubMed ID: 30890428
[TBL] [Abstract][Full Text] [Related]
8. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
[TBL] [Abstract][Full Text] [Related]
9. FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2
O'Brien A; Zhou T; White T; Medford A; Chen L; Kyritsi K; Wu N; Childs J; Stiles D; Ceci L; Chakraborty S; Ekser B; Baiocchi L; Carpino G; Gaudio E; Wu C; Kennedy L; Francis H; Alpini G; Glaser S
Hepatol Commun; 2022 Jul; 6(7):1574-1588. PubMed ID: 35271760
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
[TBL] [Abstract][Full Text] [Related]
11. Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
Petrescu AD; Grant S; Williams E; Frampton G; Parks N; Blaney H; Davies M; John R; Reinhart EH; McMillin M; DeMorrow S
Am J Pathol; 2020 Mar; 190(3):586-601. PubMed ID: 31953035
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2
Hall C; Ehrlich L; Meng F; Invernizzi P; Bernuzzi F; Lairmore TC; Alpini G; Glaser S
J Surg Res; 2017 Sep; 217():160-169. PubMed ID: 28602220
[TBL] [Abstract][Full Text] [Related]
13. NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6.
Yu F; Jiang Z; Chen B; Dong P; Zheng J
J Mol Med (Berl); 2017 Nov; 95(11):1191-1202. PubMed ID: 28864835
[TBL] [Abstract][Full Text] [Related]
14. The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice.
Wu N; Meng F; Invernizzi P; Bernuzzi F; Venter J; Standeford H; Onori P; Marzioni M; Alvaro D; Franchitto A; Gaudio E; Glaser S; Alpini G
Hepatology; 2016 Sep; 64(3):865-79. PubMed ID: 27115285
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2
Zhou T; Kyritsi K; Wu N; Francis H; Yang Z; Chen L; O'Brien A; Kennedy L; Ceci L; Meadows V; Kusumanchi P; Wu C; Baiocchi L; Skill NJ; Saxena R; Sybenga A; Xie L; Liangpunsakul S; Meng F; Alpini G; Glaser S
EBioMedicine; 2019 Oct; 48():130-142. PubMed ID: 31522982
[TBL] [Abstract][Full Text] [Related]
16. Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2
Zhou T; Wu N; Meng F; Venter J; Giang TK; Francis H; Kyritsi K; Wu C; Franchitto A; Alvaro D; Marzioni M; Onori P; Mancinelli R; Gaudio E; Glaser S; Alpini G
Lab Invest; 2018 Nov; 98(11):1449-1464. PubMed ID: 29977037
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice.
Jones H; Hargrove L; Kennedy L; Meng F; Graf-Eaton A; Owens J; Alpini G; Johnson C; Bernuzzi F; Demieville J; DeMorrow S; Invernizzi P; Francis H
Hepatology; 2016 Oct; 64(4):1202-1216. PubMed ID: 27351144
[TBL] [Abstract][Full Text] [Related]
18. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
[TBL] [Abstract][Full Text] [Related]
19. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]